Follow Julie Beyrer, DrPH
Follow Julie Beyrer, DrPH
Make a free account and we’ll email you when they’re booked to speak, or their slides or recordings are posted.
Get an email when they’re booked to speak.
Julie Beyrer, DrPH
Eli Lilly & Co.
Director, Neuroscience Medical Affairs (HEOR)
Julie Beyrer, DrPH, MPH, MTSC, is Director of Neuroscience Medical Affairs HEOR at Eli Lilly and Company, where she leads real-world evidence (RWE) strategy and execution for Alzheimer's disease. Julie has spent much of her career on the definition problem: how real-world data algorithms and codes are built, validated, and judged fit for purpose. Past and current endeavors include developing and validating claims-based algorithms for oncology and Alzheimer’s Disease HEOR and building related tools for HEOR scientists. Tools include developing and validating a Charlson Comorbidity Index ICD-10-CM adaptation for the United States with IBM Watson Health and co-creating the ACE-IT, an appraisal tool for RWE algorithm fit-for-purpose, with the FDA Reagan-Udall Foundation.
1 talk
Speaking
2027
-
Mar 1–4
SCOPE Summit 2027 Upcoming